Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance

Go back to Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 4.26 -0.03 (0.7%)
Previous Close $4.29    52 Week High $16.89 
Open $4.26    52 Week Low $7.35 
Day High $4.33    P/E N/A 
Day Low $4.22    EPS $-2.35 
Volume 829,291